G Richmond, MD
Allergy & Immunology · Hinsdale, ILNPI 1508885385
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $14,385 of the $15,893 with a category attached, or 90.5%. 4 manufacturers reported payments, led by Shire North American Group Inc at 39.6% of the total. Reporting peaked in 2019 at $11,453 and has fallen 99.8% since, to $18 in 2023.
Across 21 payments — averaging $756.79 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Shire North American Group Inc$6K
- Pharming Healthcare, Inc.$5K
- Grifols USA, LLC$4K
- Bio Products Laboratory USA, Inc.$29
What the payments were for
- Speaking & faculty fees$14,38591%
- Travel & lodging$1,2448%
- Food & beverage$2632%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Shire North American Group Inc | 6 | $6,286 |
| Pharming Healthcare, Inc. | 9 | $5,168 |
| Grifols USA, LLC | 4 | $4,410 |
| Bio Products Laboratory USA, Inc. | 2 | $29 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$15,893 in reported general payments places this provider in the 80th percentile of 161 allergy & immunology providers in Illinois.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OrladeyoBerotralstat Hydrochloride | 11 | $486,532 |
| Dupixent PenDupilumab | 16 | $92,752 |
| IcatibantIcatibant Acetate | 19 | $89,305 |
| PrivigenImmun Glob G(Igg)/Pro/Iga 0-50 | 13 | $72,682 |
| HizentraImmun Glob G(Igg)/Pro/Iga 0-50 | 12 | $37,996 |
| Breo ElliptaFluticasone/Vilanterol | 20 | $13,011 |
| Pulmicort FlexhalerBudesonide | 21 | $5,869 |
| Epinephrine | 26 | $5,637 |
| XareltoRivaroxaban | 11 | $5,562 |
| DuleraMometasone/Formoterol | 11 | $5,485 |
| SymbicortBudesonide/Formoterol Fumarate | 14 | $5,292 |
| Arnuity ElliptaFluticasone Furoate | 13 | $3,536 |
| Fluticasone-SalmeterolFluticasone Propion/Salmeterol | 27 | $3,350 |
| Montelukast Sodium | 98 | $1,748 |
| Ipratropium Bromide | 59 | $1,743 |
Paid to pharmacies, not to this prescriber.
Other allergy & immunology in Hinsdale
- Mark JacobsonHinsdale$14K
- Manika GirdharHinsdale$9K
- Dareen SiriNormal$1.5M
- Priya BansalSaint Charles$1.3M
- Anju PetersChicago$563K
- Giselle MosnaimChicago$331K
- Patrick WinShiloh$258K
- Amanda SalihChicago$160K
- Rebecca HoffmanWilmette$160K
- Juanita MoraChicago$147K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.